NEW YORK, June 29 (GenomeWeb News) - Genedata will continue to provide Altana Pharma with its scientific computational platform, the Basel, Switzerland-based company said today.

 

Under the expanded collaboration, Altana will use Genedata's platform for target identification, target validation, and lead discovery.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligences for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.